Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates a site update with no changes to study data or page content.
    Difference
    0.0%
    Check dated 2026-08-09T12:23:56.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page/template rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-25T23:57:37.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a small internal update to the site's underlying system. It does not modify the study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T08:20:32.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A newer revision number (v3.6.2) is now shown, indicating a behind-the-scenes update to the site. This update does not modify the study information displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-27T05:34:57.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    New navigation/help sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and a version update indicates v3.6.0. The investigator name presentation and related metadata were adjusted (e.g., William Gradishar entry and related labels).
    Difference
    1%
    Check dated 2026-06-13T00:20:30.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor page update or bug fix. It does not appear to modify the study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.